Mark Dybul
2020
In 2020, Mark Dybul earned a total compensation of $1.3M as Executive Vice Chair at Enochian Biosciences, a 33% decrease compared to previous year.
Compensation breakdown
| Option Awards | $832,500 |
|---|---|
| Salary | $430,000 |
| Total | $1,262,500 |
Dybul received $832.5K in option awards, accounting for 66% of the total pay in 2020.
Dybul also received $430K in salary.
Rankings
In 2020, Mark Dybul's compensation ranked 7,612th out of 13,090 executives tracked by ExecPay. In other words, Dybul earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,612 out of 13,090 | 42nd |
Division Manufacturing | 3,209 out of 5,618 | 43rd |
Major group Chemicals And Allied Products | 1,295 out of 2,251 | 43rd |
Industry group Drugs | 1,121 out of 1,951 | 43rd |
Industry Pharmaceutical Preparations | 836 out of 1,456 | 43rd |
Source: SEC filing on February 3, 2021.
Dybul's colleagues
We found one more compensation record of an executive who worked with Mark Dybul at Enochian Biosciences in 2020.
2020
Luisa Puche
Enochian Biosciences